Skip to main content
. 2018 Sep 27;22:17-207. doi: 10.7812/TPP/17-207

Table 3.

CAPS-5 scores for all patients in the study of a therapy to reduce noncombat-related PTSD symptomsa

CAPS-5 Scores Initial, no. (%) Posttreatment, no. (%) Follow-up, no. (%)
Yes No Yes No Yes No
PTSD diagnosis present 30 (100) 0 (0) 0 (0) 26 (100) 1 (4) 24 (96)
Dissociative subtype 13 (43) 17 (57) 2 (8) 24 (92) 2 (8) 22 (92)
Distressing dreams (B2) 15 (50) 15 (50) 1 (4) 25 (96) 3 (13) 21 (87)
Sleep disturbance (E6) 21 (70) 9 (30) 6 (23) 20 (77) 4 (17) 20 (83)
Score averagesb
Average total score for criteria B–E 44.93 (80) 10.46 (80) 8.66 (80)
Criterion B average 12.5 (20) 3.42 (20) 1.96 (20
Criterion C average 5.97 (8) 23 (8 0.17 (8
Criterion D average 15.7 (28) 3.42 (28) 3.29 (28)
Criterion E average 10.5 (24) 3.27 (24) 2.46 (24)
Subjective distress average 3.23 (4) 1 (4) 1 (4)
Social impairment average 2.43 (4) 0.69 (4) 0.67 (4)
Occupational impairment average 2 (4) 0.69 (4) 0.54 (4)
Global severity average 2.9 (4) 0.9 (4) 0.75 (4)
Global improvement average 1.69 (4) 1.63 (4)
a

There were 30 patients in the pretreatment group, 26 patients in the posttreatment group, and 24 patients in the follow-up (at 3 months) group.

b

Average score followed by total possible score for that category.

CAPS-5 = Clinician-Administered PTSD Scale for Diagnostic and Statistical Manual, Fifth Edition; PTSD = posttraumatic stress disorder.